miRs-138 and -424 control palmitoylation-dependent CD95-mediated cell death by targeting acyl protein thioesterases 1 and 2 in chronic lymphocytic leukemia
暂无分享,去创建一个
P. Bastiaens | M. Hallek | H. Waldmann | A. Schauss | C. Wendtner | C. Jüngst | C. Pallasch | L. Frenzel | C. Hedberg | N. Vartak | Marion Rusch | Valeska Berg
[1] Hong Yu,et al. miR‐138 inhibits proliferation by targeting 3‐phosphoinositide‐dependent protein kinase‐1 in non‐small cell lung cancer cells , 2015, The clinical respiratory journal.
[2] Alfonso Valencia,et al. Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia , 2014, Genome research.
[3] S. Nussberger,et al. S-palmitoylation represents a novel mechanism regulating the mitochondrial targeting of BAX and initiation of apoptosis , 2014, Cell Death and Disease.
[4] P. Bastiaens,et al. The autodepalmitoylating activity of APT maintains the spatial organization of palmitoylated membrane proteins. , 2014, Biophysical journal.
[5] Aneela Majid,et al. A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia , 2013, Nature Genetics.
[6] X. Wang,et al. Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer , 2013, Oncogene.
[7] M. Peter,et al. CD95 Is Part of a Let-7/p53/miR-34 Regulatory Network , 2012, PloS one.
[8] M. Hallek,et al. B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides. , 2012, Blood.
[9] C. Croce,et al. The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. , 2012, Blood.
[10] G. Salles,et al. In non‐follicular lymphoproliferative disorders, IGH/BCL2‐fusion is not restricted to chronic lymphocytic leukaemia , 2012, British journal of haematology.
[11] Maria Anna Rapsomaniki,et al. easyFRAP: an interactive, easy-to-use tool for qualitative and quantitative analysis of FRAP data , 2012, Bioinform..
[12] J. Byrd,et al. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia. , 2012, Cancer research.
[13] M. Shipston,et al. Distinct Acyl Protein Transferases and Thioesterases Control Surface Expression of Calcium-activated Potassium Channels* , 2012, The Journal of Biological Chemistry.
[14] E. Giné,et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia , 2011, Nature Genetics.
[15] Benjamin F. Cravatt,et al. Global profiling of dynamic protein palmitoylation , 2011, Nature Methods.
[16] I. Vetter,et al. Identification of acyl protein thioesterases 1 and 2 as the cellular targets of the Ras-signaling modulators palmostatin B and M. , 2011, Angewandte Chemie.
[17] Stefano Volinia,et al. miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia. , 2011, Blood.
[18] G. Gores,et al. High Cell Surface Death Receptor Expression Determines Type I Versus Type II Signaling* , 2011, The Journal of Biological Chemistry.
[19] Juliane C. Dohm,et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia , 2011, Nature.
[20] A. Martínez-Ruíz,et al. S-nitrosylation of the death receptor fas promotes fas ligand-mediated apoptosis in cancer cells. , 2011, Gastroenterology.
[21] C. Plass,et al. Sustained NF‐kappaB activity in chronic lymphocytic leukemia is independent of genetic and epigenetic alterations in the TNFAIP3 (A20) locus , 2011, International journal of cancer.
[22] Mahiuddin Ahmed,et al. FKBP12 binds to acylated H-ras and promotes depalmitoylation. , 2011, Molecular cell.
[23] M. Hallek,et al. Novel X‐linked inhibitor of apoptosis inhibiting compound as sensitizer for TRAIL‐mediated apoptosis in chronic lymphocytic leukaemia with poor prognosis , 2011, British journal of haematology.
[24] Guillermo A. Gomez,et al. Acyl-Protein Thioesterase 2 Catalizes the Deacylation of Peripheral Membrane-Associated GAP-43 , 2010, PloS one.
[25] Stefan Wetzel,et al. Small-molecule inhibition of APT1 affects Ras localization and signaling. , 2010, Nature chemical biology.
[26] C. Croce,et al. MicroRNAs as regulators of death receptors signaling , 2010, Cell Death and Differentiation.
[27] P. Bastiaens,et al. The Palmitoylation Machinery Is a Spatially Organizing System for Peripheral Membrane Proteins , 2010, Cell.
[28] Andrea Califano,et al. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. , 2010, Cancer cell.
[29] E. Campo,et al. Common variants at 2q37.3, 8q24.21, 15q21.3, and 16q24.1 influence chronic lymphocytic leukemia risk , 2010, Nature Genetics.
[30] Michael Hallek,et al. miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia. , 2009, Blood.
[31] Hanno Steen,et al. Proteome Scale Characterization of Human S-Acylated Proteins in Lipid Raft-enriched and Non-raft Membranes* , 2009, Molecular & Cellular Proteomics.
[32] M. Greenberg,et al. A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis , 2009, Nature Cell Biology.
[33] Brent R. Martin,et al. Large-scale profiling of protein palmitoylation in mammalian cells , 2009, Nature Methods.
[34] Y. Ho,et al. Redox amplification of apoptosis by caspase-dependent cleavage of glutaredoxin 1 and S-glutathionylation of Fas , 2009, The Journal of cell biology.
[35] D. Bartel. MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.
[36] F. G. van der Goot,et al. Palmitoylation of membrane proteins (Review) , 2009, Molecular membrane biology.
[37] Guy Pratt,et al. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia , 2008, Nature Genetics.
[38] A. Ultsch,et al. Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells , 2008, Leukemia.
[39] A. Bailey,et al. Palmitoylated proteins: purification and identification , 2007, Nature Protocols.
[40] H. Ploegh,et al. Chemical probes for the rapid detection of Fatty-acylated proteins in Mammalian cells. , 2007, Journal of the American Chemical Society.
[41] D. Marguet,et al. Palmitoylation is required for efficient Fas cell death signaling , 2007, The EMBO journal.
[42] M. Peter,et al. Palmitoylation of CD95 facilitates formation of SDS‐stable receptor aggregates that initiate apoptosis signaling , 2007, The EMBO journal.
[43] R. Deschenes,et al. Thematic review series: Lipid Posttranslational Modifications. Protein palmitoylation by a family of DHHC protein S-acyltransferases Published, JLR Papers in Press, April 1, 2006. , 2006, Journal of Lipid Research.
[44] T. Kipps,et al. Inhibitors of XIAP sensitize CD40-activated chronic lymphocytic leukemia cells to CD95-mediated apoptosis. , 2005, Blood.
[45] T. Kipps,et al. Fas-ligand (CD178) and TRAIL synergistically induce apoptosis of CD40-activated chronic lymphocytic leukemia B cells. , 2005, Blood.
[46] B. Rotoli,et al. Induction of CD95 upregulation does not render chronic lymphocytic leukemia B-cells susceptible to CD95-mediated apoptosis. , 2005, Immunology letters.
[47] R. Birge,et al. Fas engagement induces neurite growth through ERK activation and p35 upregulation , 2003, Nature Cell Biology.
[48] E. Lai. Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation , 2002, Nature Genetics.
[49] P. Krammer,et al. CD95's deadly mission in the immune system , 2000, Nature.
[50] T. Michel,et al. Depalmitoylation of Endothelial Nitric-oxide Synthase by Acyl-protein Thioesterase 1 Is Potentiated by Ca2+-Calmodulin* , 1999, The Journal of Biological Chemistry.
[51] P. Guldberg,et al. Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity. , 1998, Blood.
[52] A. Hall,et al. Dynamic fatty acylation of p21N‐ras. , 1987, The EMBO journal.
[53] Sun-Mi Park,et al. CD95 promotes tumour growth , 2011, Nature.
[54] Y. Pekarsky,et al. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. , 2006, Cancer research.
[55] R. Foà,et al. Resistance to CD95-mediated apoptosis of CD40-activated chronic lymphocytic leukemia B cells is not related to lack of DISC molecules expression. , 2004, The hematology journal : the official journal of the European Haematology Association.
[56] S. Molica,et al. Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis. , 1996, Haematologica.